Abstract
The kidney performs three essential functions: the excretory, the regulatory and the endocrine functions; this contributes to the complexity of anatomy and physiology of the human renal system. Non-invasive radionuclide procedures in the evaluation of renal diseases have been accepted increasingly as effective and valuable alternatives to older clinical methods: in fact “in vivo” nuclear medicine allows assessment of the three renal processes involved in the elaboration of urine: glomerular filtration, tubular reabsorption and tubular secretion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
General References
- Blaufox MD, Evaluation of renal function and disease with radionuclides. S. Karger, Basle, 1972.
- Chervu LR, et al, Radiopharmaceuticals for renal studies. Sem. Nucl. Med. 4:3, 1974.
- Arnold RW, et al, Comparison of 99mTc complexes for renal imaging. J. Nucl. Med. 16:357, 1975.
- Jakubowski W, et al, Comparative investigations of renal scanning agents. Eur. J. Nucl. Med. 3:33, 1978.
- Noronha OPD, et al, On the nature of technetium compounds. Eur. J. Nucl. Med. 6:121, 1980.
- McAfee JG, et al, Comparison of renal extraction efficiencies for radioactive agents in the normal dog. J. Nucl. Med. 22:333, 1981.
- Cox PH, Technetium complexes for renal scintigraphy. In: Proc. in Radiopharmacology, Vol. 3, Cox PH, (ed), M. Nijhoff Publ., The Hague, 1982.
- Chervu LR, et al, Renal Radiopharmaceuticals: an update. Sem. Nucl. Med. 12:224, 1982.
- Dubovsky EV, et al, Quantitation of renal function with glomerular and tubular agents. Sem. Nucl. Med. 12:308, 1982.
- Taylor A, et al, Differential renal function in unilateral renal injury: possible effects of radiopharmaceutical choice. J. Nucl. Med. 26:77, 1985.
References for GRF
- McChesney EW, et al, Studies of the tissue distribution and excretion of sodium diatrizoate in laboratory animals. Amer. J. Roentgenol. 78:137, 1957.
- Winter CC, et al, Three new test agents for the radioisotope renogram: DISA-I131; EDTA-Cr51; and Hippuran-I125. J. Nucl. Med. 3:273, 1962.
- Blaufox MD, et al, Plasmatic diatrozoate-I131 disappearance and glomerular filtration in the dog. Amer. J. Physiol. 204:536, 1963.
- Griep RJ, et al, Mechanisms of excretion of radioiodinated sodium iothalamate. Radiology 93:807, 1969.
- Hauser W, et al, Technetium-99m DTPA: A new radiopharmaceutical for brain and kidney scanning. Radiology 94:679, 1970.
- Klopper FJ, et al, Evaluation of 99mTc-DTPA for the measurement of glomerular filtration rate. J. Nucl. Med. 13:107, 1972.
- Reba RC, et al, Radiolabeled chelates for visualization of kidney function and structure with emphasis on their use in renal insufficiency. Sem. Nucl. Med. 4:151, 1974.
- Agha N, et al, Comparative labelling on biokinetic studies of 99mTc-EDTA (Sn) and 99mTc-DTPA(Sn). Nucl. Med. 16:30, 1977.
- Saha BG, et al, Measurement of renal function with 111In-DTPA in dogs. Int. J. Nucl. Med. Biol. 4:99, 1977.
- Johansson RS, et al, 113mIn-DTPA, a useful compound for the determination of glomerular filtration rate (GFR). Eur. J. Nucl. Med. 3:179, 1978.
- McAfee JG, et al, Biological distribution and excretion of DTPA labelled with Tc-99m and In-111. J. Nucl. Med. 20:1273, 1979.
- Carlsen JE, et al, Comparison of four commercial Tc-99m(Sn) DTPA preparations used for the measurement of glomerular filtration rate: Concise communication. J. Nucl. Med. 21:126, 1980.
- Swick M, Excretion urography by means of the intravenous and oral administration of sodium ortho-iodohippurate with some physiological considerations. Surg. Gynec. Obstet. 56:62, 1983.
- Konilowski T, et al, Renal clearance in mice as a bioassay for radiopharmaceuticals: Intercomparison of commercial sources of iodohippurate sodium 131I(OIH). Int. J. Nucl. Med. Biol. 1:37, 1973.
- Assailly J, et al, Noninvasive experimental determination of the individual kidney filtration fraction by means of a dual-tracer technique. J. Nucl. Med. 18:684, 1977.
- Bögl W, et al, Chemische Form der radioaktiven Ausscheidungsprodukte nach intravenöser Verabreichung von 125J-Orthojodhippuran an Ratten. Nucl. Med. 17,2:53, 1978.
- Stadalnik RC, et al, Renal clearance and extraction parameters of ortho-iodohippurate (I-123) compared with OIH(I-131) and PAH. J. Nucl. Med. 21:168, 1980.
- Kaspersen FM, et al, Radioiodinated o-iodobenzoic acid as impurity in hippuran preparations. Int. J. appl. Radiat. Isot. 31:97, 1979.
- Fritzberg AR, et al, Biodistribution and renal excretion of 99mTcN,N′-bis-(Mercaptoacetamido) ethylenediamine. Effect of renal tubular transport inhibitors. Int. J. Nucl. Med. Biol. 9:79, 1982.
- Fritzberg AR, et al, Chemical and biological studies of Tc-99m (N,N′-Bis (Mercaptoacetamido)-ethylenediamine): A potential replacement for I-131 iodohippurate. J. Nucl. Med. 22:258, 1981.
- Klingensmith WC, et al, Clinical comparison of Tc-99m (N,N′-Bis(Mercaptoacetamido) ethylenediamine) and 131I ortho-iodohippurate for evaluation of renal tubular function. J. Nucl. Med. 23:377, 1982.
- Ogiunski M, et al, Comparative evaluation of renoscintigraphic properties and plasma clearance of (99mTc-DADS (99mTc-N,N′-Bis/-Mercaptoacetamido ethylenediamine), 99mTc-DTPA and 131I-o-hippuran. Nucl. Med. 22:136, 1983.
- Subramanian G, et al, Structure distribution relationship in the design of Tc-99m radiopharmaceuticals. In: Safety and efficacy of Radiopharmaceuticals. Kristensen K, Norbygaard W, (eds), M. Nijhoff, Publ., The Hague, 1984.
- Klingensmith WC, et al, Clinical evaluation of Tc-99m N,N′-Bis (Mercaptoacetyl)-2,3-diaminopropanate as a replacement for I-131 hippurate. J. Nucl. Med. 24:42, 1984.
- Chervu LR, et al, Technetium-99m-labeled P-aminohippuric acid analog: A new renal agent. J. Nucl. Med. 25:1111, 1984.
References for Kidney Morphology
- Kloss G, Strahlehbelastung durch Hg203-markierte Testpräparate zur Nierendiagnostik. Nucl. Med. III,1:82, 1962.
- Jovanovic V, et al, Biological and chemical properties of 197Hg chlormerodrin. Nucl. Med. 12:335, 1973.
- Pedroso De Lima JJ, et al, Die renale Szintigraphie mit 131J-trasylol. Nucl. Med. 12:26, 1973.
- Lin TH, et al, A 99mTc-chelate substitute for organoradiomercurial renal agents. J. Nucl. Med. 15:34, 1974.
- Berkes I, et al, The synthesis and chemical properties of 3-chloromercury-2-hydroxipropyl-urea. Nucl. Med. 14:374, 1975.
- MIRD, Summary of current radiation dose estimates to humans from 197Hg- and 203Hg-labeled chlormerodrin. J. Nucl. Med. 16:1095, 1975.
- Vanlic-Razumenic NM, et al, Studies of chemical and biological properties of 99mTc-DNS (dimercaptosuccinic acid) — renal imaging agent. Eur. J. Nucl. Med. 1:235, 1976.
- Ikeda I, et al, Chemical and biological studies on 99mTc-DMS-I: Formation of complexes by four different methods. Int. J. Nucl. Med. Biol. 4:56, 1977.
- Ikeda I, et al, Preparation of various Tc-99m dimercaptosuccinate complexes and their evaluation as radiotracers. J. Nucl. Med. 18:1222, 1977.
- Daly MJ, et al, Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): In vitro correlation. J. Nucl. Med. 20:63, 1979.
- Kubiatowicz DO, et al, Localization of low molecular weight 99mTc-labeled dimercaptodicarboxylic acids in kidney tissue. J. Pharm. Sci. 68:621, 1979.
- Taylor A, et al, Optimal handling of dimercaptosuccinic acid for quantitative renal scanning. J. Nucl. Med. 21:1190, 1980.
- Vanlic-Razumenic N, et al, Biochemical studies of the renal radiopharmaceutical compound dimercaptosuccinate. I. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo. Eur. J. Nucl. Med. 6:169, 1981.
II. Subcellular localization of 99mTc-DMS complex in the rat kidney in vivo. Eur. J. Nucl. Med. 7:304, 1982.
III. Subcellular distribution and interaction of 99mTc-DMS complex with macromolecules in rat kidney homogenates in vitro. Eur. J. Nucl. Med. 7:308, 1982.
- Vanlic-Razumenic N, Comparative examinations of 99mTc-DMS preparations obtained by labelling dimercaptosuccinate kits with different formulations. Nucl. Med. 20:46, 1981.
- Yee CA, et al, 99mTc-DMSA renal uptake: Influence of biochemical and physiologic factors. J. Nucl. Med. 22:1054, 1981.
- Bianchi C, et al, Aprotinin 99mTc: A new tracer for the study of kidney morphology and function. In: Secondary forms of hypertension. Current diagnosis and management. Blaufox MD, (ed), Grune and Stratton, New York, pp 289–308, 1981.
- Bianchi C, et al, 99mTc-aprotinin; a low molecular weight protein for the study of renal function. In: Radioaktive Isotope in Klinik und Forschung. Gasteiner Int. Symp. pp 315–321, 1981.
- Bianchi C, et al, Aprotinin 99mTc: A new tracer for kidney imaging and unilateral renal function studies. Proc. 3rd World Congr. Nucl. Med. Biol. pp 2756–2760, 1982.
- Taylor A, Quantitation of renal function with static imaging agents. Sem. Nucl. Med. 12:330, 1982.
- Vanlic-Razumenic N, et al, In vivo localization of chlormerodrin-203Hg in rat kidney as determined by cell fractionation method. Strahlentherapie 159:28, 1983.
- Aprile C, et al, 99mTc-aprotinin: Comparison with 99mTc-DMSA in normal and diseased kidneys. Nuklearmedizin 23:22, 1984.
- Moretti JL, et al, 2,3-dimercaptosuccini-acid chelates — II Renal Localization. Int. J. Nucl. Med. Biol. 11:275, 1984.
References on Mixed Compounds
- De Filippi PG, et al, 99mTc-gluconate complex for kidney scanning. J. Nucl. Biol. Med. 19:58, 1975.
- Hambright P, et al, Chemistry of technetium radiopharmaceuticals. I. Exploration of the tissue distribution and oxidation state consequences of technetium (IV) in Tc-Sn-gluconate and Tc-Sn-EHDP using carrier 99mTc. J. Nucl. Med. 16:478, 1976.
- Vanlic-Razumenic N, et al, Comparative chemical, biological and clinical studies of 99mTc-glucoheptonate and 99mTc-dimercaptosuccinate as used in renal scintigraphy. Nucl. Med. 18:40, 1979.
- Agha NH, et al, Instant 99mTc-labelled glucoheptonate kit for kidney imaging. Nucl. Med. 22:246, 1983.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Martinus Nijhoff Publishers, Dordrecht
About this chapter
Cite this chapter
Villa, M., Saccavini, J.C., Bardy, A. (1986). Biological Fate of Renal Agents. In: Cox, P.H., Mather, S.J., Sampson, C.B., Lazarus, C.R. (eds) Progress in Radiopharmacy. Developments in Nuclear Medicine, vol 10. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4297-4_21
Download citation
DOI: https://doi.org/10.1007/978-94-009-4297-4_21
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8410-9
Online ISBN: 978-94-009-4297-4
eBook Packages: Springer Book Archive